MEDI4920
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MEDI4920, covering 2019-02-15 to 2019-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b Study of MEDI4920 in Participants With Adult-onset Rheumatoid Arthritis [Phase 1]